News

Liquid Instruments, a leader in reconfigurable test and measurement technology, today announced the appointment of two new ...
QKS Group, a premier market intelligence and advisory firm, has released its latest in-depth analysis of the global Enterprise Integration Platform as a Service (EiPaaS) Market, projecting a compound ...
A state appeal court ruled that Fresno County does not have standing when challenging a lawsuit over a state law banning ...
Monument Therapeutics, a precision-neuroscience company focused on the development of innovative treatments for serious central nervous system disorders (CNS), today announced two key leadership ...
"While there is nothing unusual about a new administration reversing a predecessor’s policies, here, the depth and breadth of ...
Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...
We are delighted to welcome Professor Shechtman to our Scientific Advisory Board,” said Amir Avniel, CEO of NeuroNOS. “The addition of Professor Shechtman, alongside Professor Roger Kornberg from ...
Littman is a co-founder of Vendanta Biosciences and ImmunAI, and serves on the advisory boards of IMIDomics, Sonoma Biotherapeutics, NILO Therapeutics, and Evommune, and on the board of directors of ...
“Only the Supreme Court can decide the dispute and, in my opinion, the sooner, the better," a dissenting judge wrote. By Jordan Rubin UPDATE (April 9, 2025, 4:33 p.m. ET): Chief Justice John ...
Experts say outbreaks of preventable diseases could get much worse with Trump’s cuts to public health infrastructure.